3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
3
Sarcoma
1
Myeloid
1
Conditions
Sarcoma
9
Rhabdomyosarcoma
4
Rhabdoid Tumor
4
Osteosarcoma
4
Central Nervous System Neoplasms
4
Brain Neoplasms
4
Neuroectodermal Tumors, Primitive, Peripheral
3
Neuroblastoma
3
Medulloblastoma
3
Testicular Neoplasms
2
Testicular Germ Cell Tumor
2
Spinal Cord Neoplasms
2
Sarcoma, Ewing
2
Ovarian Neoplasms
2
Neoplasms, Germ Cell and Embryonal
2
Kidney Neoplasms
2
Choroid Plexus Neoplasms
2
Carcinoma, Renal Cell
2
Astrocytoma
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Teratoma
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Retinoblastoma
1
Recurrence
1
Pinealoma
1
Ovarian Germ Cell Cancer
1
Optic Nerve Glioma
1
Interventions
Magnetic Resonance Spectroscopy
15
Temozolomide
14
Radiotherapy
6
Filgrastim
6
Carmustine
6
Biopsy
6
X-Rays
5
Phantoms, Imaging
5
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
5
sargramostim
4
Specimen Handling
4
Peripheral Blood Stem Cell Transplantation
4
Nuclear Medicine Department, Hospital
4
Cyclophosphamide
4
olaparib
3
Thiotepa
3
Gadolinium DTPA
3
Cisplatin
3
Carboplatin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fluorodopa F 18
2
ensartinib
2
aldesleukin
2
Yoga
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ependymoma
×
etoposide phosphate
×
Sarcoma
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled